Literature DB >> 23136059

Geographical distribution and oncogenic risk association of human papillomavirus type 58 E6 and E7 sequence variations.

Paul K S Chan1, Chuqing Zhang, Jong-Sup Park, Karen K Smith-McCune, Joel M Palefsky, Lucia Giovannelli, Francois Coutlée, Samantha Hibbitts, Ryo Konno, Wannapa Settheetham-Ishida, Tang-Yuan Chu, Annabelle Ferrera, María Alejandra Picconi, Federico De Marco, Yin-Ling Woo, Tainá Raiol, Patricia Piña-Sánchez, Jeong-Hoon Bae, Martin C S Wong, Mike Z Chirenje, Tsitsi Magure, Anna-Barbara Moscicki, Alison N Fiander, Giuseppina Capra, Eun Young Ki, Yi Tan, Zigui Chen, Robert D Burk, Martin C W Chan, Tak-Hong Cheung, David Pim, Lawrence Banks.   

Abstract

Human papillomavirus (HPV) 58 accounts for a notable proportion of cervical cancers in East Asia and parts of Latin America, but it is uncommon elsewhere. The reason for such ethnogeographical predilection is unknown. In our study, nucleotide sequences of E6 and E7 genes of 401 HPV58 isolates collected from 15 countries/cities across four continents were examined. Phylogenetic relationship, geographical distribution and risk association of nucleotide sequence variations were analyzed. We found that the E6 genes of HPV58 variants were more conserved than E7. Thus, E6 is a more appropriate target for type-specific detection, whereas E7 is more appropriate for strain differentiation. The frequency of sequence variation varied geographically. Africa had significantly more isolates with E6-367A (D86E) but significantly less isolates with E6-203G, -245G, -367C (prototype-like) than other regions (p ≤ 0.003). E7-632T, -760A (T20I, G63S) was more frequently found in Asia, and E7-793G (T74A) was more frequent in Africa (p < 0.001). Variants with T20I and G63S substitutions at E7 conferred a significantly higher risk for cervical intraepithelial neoplasia grade III and invasive cervical cancer compared to other HPV58 variants (odds ratio = 4.44, p = 0.007). In conclusion, T20I and/or G63S substitution(s) at E7 of HPV58 is/are associated with a higher risk for cervical neoplasia. These substitutions are more commonly found in Asia and the Americas, which may account for the higher disease attribution of HPV58 in these areas.
Copyright © 2012 UICC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23136059      PMCID: PMC3962828          DOI: 10.1002/ijc.27932

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  31 in total

1.  Datamonkey 2010: a suite of phylogenetic analysis tools for evolutionary biology.

Authors:  Wayne Delport; Art F Y Poon; Simon D W Frost; Sergei L Kosakovsky Pond
Journal:  Bioinformatics       Date:  2010-07-29       Impact factor: 6.937

2.  A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia.

Authors:  Mark Schiffman; Ana Cecilia Rodriguez; Zigui Chen; Sholom Wacholder; Rolando Herrero; Allan Hildesheim; Rob Desalle; Brian Befano; Kai Yu; Mahboobeh Safaeian; Mark E Sherman; Jorge Morales; Diego Guillen; Mario Alfaro; Martha Hutchinson; Diane Solomon; Philip E Castle; Robert D Burk
Journal:  Cancer Res       Date:  2010-03-30       Impact factor: 12.701

3.  Intratype variation in 12 human papillomavirus types: a worldwide perspective.

Authors:  A C Stewart; A M Eriksson; M M Manos; N Muñoz; F X Bosch; J Peto; C M Wheeler
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

4.  High prevalence and low E6 genetic variability of human papillomavirus 58 in women with cervical cancer and precursor lesions in Southeast Mexico.

Authors:  Jaqueline Canul Canche; Iván Rosado López; Nicolás G Suárez; Gladis Colli Acosta; Laura Conde-Ferráez; Thelma Canto de Cetina; María R González Losa
Journal:  Mem Inst Oswaldo Cruz       Date:  2010-03       Impact factor: 2.743

5.  Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.

Authors:  Silvia de Sanjose; Wim Gv Quint; Laia Alemany; Daan T Geraets; Jo Ellen Klaustermeier; Belen Lloveras; Sara Tous; Ana Felix; Luis Eduardo Bravo; Hai-Rim Shin; Carlos S Vallejos; Patricia Alonso de Ruiz; Marcus Aurelho Lima; Nuria Guimera; Omar Clavero; Maria Alejo; Antonio Llombart-Bosch; Chou Cheng-Yang; Silvio Alejandro Tatti; Elena Kasamatsu; Ermina Iljazovic; Michael Odida; Rodrigo Prado; Muhieddine Seoud; Magdalena Grce; Alp Usubutun; Asha Jain; Gustavo Adolfo Hernandez Suarez; Luis Estuardo Lombardi; Aekunbiola Banjo; Clara Menéndez; Efrén Javier Domingo; Julio Velasco; Ashrafun Nessa; Saibua C Bunnag Chichareon; You Lin Qiao; Enrique Lerma; Suzanne M Garland; Toshiyuki Sasagawa; Annabelle Ferrera; Doudja Hammouda; Luciano Mariani; Adela Pelayo; Ivo Steiner; Esther Oliva; Chris Jlm Meijer; Waleed Fahad Al-Jassar; Eugenia Cruz; Thomas C Wright; Ana Puras; Cecilia Ladines Llave; Maria Tzardi; Theodoros Agorastos; Victoria Garcia-Barriola; Christine Clavel; Jaume Ordi; Miguel Andújar; Xavier Castellsagué; Gloria I Sánchez; Andrzej Marcin Nowakowski; Jacob Bornstein; Nubia Muñoz; F Xavier Bosch
Journal:  Lancet Oncol       Date:  2010-10-15       Impact factor: 41.316

6.  Prevalence of human papillomavirus types in women with pre-neoplastic and neoplastic cervical lesions in the Federal District of Brazil.

Authors:  Geni N L Camara; Daniela M Cerqueira; Ana P G Oliveira; Evandro O Silva; Luciano G S Carvalho; Cláudia R F Martins
Journal:  Mem Inst Oswaldo Cruz       Date:  2004-01-07       Impact factor: 2.743

7.  Type-specific distribution of HPV along the full spectrum of cervical carcinogenesis in Taiwan: an indication of viral oncogenic potential.

Authors:  Dah-Ching Ding; Han-Chuan Hsu; Rui-Lan Huang; Hung-Cheng Lai; Ching-Yu Lin; Mu-Hsien Yu; Tang-Yuan Chu
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2008-05-27       Impact factor: 2.435

8.  A large case-control study of cervical cancer risk associated with human papillomavirus infection in Japan, by nucleotide sequencing-based genotyping.

Authors:  Tsuyoshi Asato; Toshiyuki Maehama; Yutaka Nagai; Koji Kanazawa; Hiroshi Uezato; Ken-Ichi Kariya
Journal:  J Infect Dis       Date:  2004-04-26       Impact factor: 5.226

9.  Distribution of human papillomavirus types in cervical cancers in Hong Kong: current situation and changes over the last decades.

Authors:  Paul K S Chan; Wendy C S Ho; Mei-Yung Yu; Wai-Mei Pong; Alexander C L Chan; Amanda K C Chan; Tak-Hong Cheung; Martin C S Wong; Ka-Fai To; Ho-Keung Ng
Journal:  Int J Cancer       Date:  2009-10-01       Impact factor: 7.396

10.  Human papillomavirus type 16 intratypic variant infection and risk for cervical neoplasia in southern China.

Authors:  Paul K S Chan; Ching Wan Lam; Tak Hong Cheung; William W H Li; Keith W K Lo; May Y M Chan; Jo L K Cheung; Li Ying Xu; Augustine F Cheng
Journal:  J Infect Dis       Date:  2002-08-05       Impact factor: 5.226

View more
  29 in total

Review 1.  Human papillomavirus genome variants.

Authors:  Robert D Burk; Ariana Harari; Zigui Chen
Journal:  Virology       Date:  2013-08-31       Impact factor: 3.616

2.  Machine Learning Interpretation of Extended Human Papillomavirus Genotyping by Onclarity in an Asian Cervical Cancer Screening Population.

Authors:  Oscar G W Wong; Idy F Y Ng; Obe K L Tsun; Herbert H Pang; Philip P C Ip; Annie N Y Cheung
Journal:  J Clin Microbiol       Date:  2019-11-22       Impact factor: 5.948

3.  Lineages of oncogenic human papillomavirus types other than type 16 and 18 and risk for cervical intraepithelial neoplasia.

Authors:  Long Fu Xi; Mark Schiffman; Laura A Koutsky; James P Hughes; Rachel L Winer; Constance Mao; Ayaka Hulbert; Shu-Kuang Lee; Zhenping Shen; Nancy B Kiviat
Journal:  J Natl Cancer Inst       Date:  2014-09-13       Impact factor: 13.506

4.  Follow-up study of HPV58 variants in women with incident HPV58 infection from a Colombian cohort.

Authors:  Mónica Molano; Oscar Buitrago; Pablo Moreno-Acosta; Suzanne M Garland; Nicolás Morales; Antonio Huertas; Teresa Martinez; Oscar Gamboa; Sepehr N Tabrizi; Alyssa Cornall; Nubia Muñoz
Journal:  Oncol Lett       Date:  2018-06-08       Impact factor: 2.967

5.  Human papillomavirus type 58 genome variations and RNA expression in cervical lesions.

Authors:  Yang Li; Xiaohong Wang; Ting Ni; Fenfen Wang; Weiguo Lu; Jun Zhu; Xing Xie; Zhi-Ming Zheng
Journal:  J Virol       Date:  2013-06-19       Impact factor: 5.103

6.  Characterization of Intra-Type Variants of Oncogenic Human Papillomaviruses by Next-Generation Deep Sequencing of the E6/E7 Region.

Authors:  Enrico Lavezzo; Giulia Masi; Stefano Toppo; Elisa Franchin; Valentina Gazzola; Alessandro Sinigaglia; Serena Masiero; Marta Trevisan; Silvana Pagni; Giorgio Palù; Luisa Barzon
Journal:  Viruses       Date:  2016-03-14       Impact factor: 5.048

7.  Classification and evolution of human papillomavirus genome variants: Alpha-5 (HPV26, 51, 69, 82), Alpha-6 (HPV30, 53, 56, 66), Alpha-11 (HPV34, 73), Alpha-13 (HPV54) and Alpha-3 (HPV61).

Authors:  Zigui Chen; Mark Schiffman; Rolando Herrero; Rob DeSalle; Kathryn Anastos; Michel Segondy; Vikrant V Sahasrabuddhe; Patti E Gravitt; Ann W Hsing; Paul K S Chan; Robert D Burk
Journal:  Virology       Date:  2018-01-11       Impact factor: 3.616

Review 8.  Current Updates on Cancer-Causing Types of Human Papillomaviruses (HPVs) in East, Southeast, and South Asia.

Authors:  Chichao Xia; Sile Li; Teng Long; Zigui Chen; Paul K S Chan; Siaw Shi Boon
Journal:  Cancers (Basel)       Date:  2021-05-30       Impact factor: 6.639

9.  Evolution and taxonomic classification of alphapapillomavirus 7 complete genomes: HPV18, HPV39, HPV45, HPV59, HPV68 and HPV70.

Authors:  Zigui Chen; Mark Schiffman; Rolando Herrero; Rob DeSalle; Kathryn Anastos; Michel Segondy; Vikrant V Sahasrabuddhe; Patti E Gravitt; Ann W Hsing; Robert D Burk
Journal:  PLoS One       Date:  2013-08-16       Impact factor: 3.240

10.  Meta-analysis on prevalence and attribution of human papillomavirus types 52 and 58 in cervical neoplasia worldwide.

Authors:  Paul K S Chan; Wendy C S Ho; Martin C W Chan; Martin C S Wong; Apple C M Yeung; Josette S Y Chor; Mamie Hui
Journal:  PLoS One       Date:  2014-09-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.